Correlation Between INmune Bio and Anixa Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Anixa Biosciences, you can compare the effects of market volatilities on INmune Bio and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Anixa Biosciences.

Diversification Opportunities for INmune Bio and Anixa Biosciences

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between INmune and Anixa is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of INmune Bio i.e., INmune Bio and Anixa Biosciences go up and down completely randomly.

Pair Corralation between INmune Bio and Anixa Biosciences

Given the investment horizon of 90 days INmune Bio is expected to generate 1.33 times more return on investment than Anixa Biosciences. However, INmune Bio is 1.33 times more volatile than Anixa Biosciences. It trades about 0.39 of its potential returns per unit of risk. Anixa Biosciences is currently generating about 0.21 per unit of risk. If you would invest  530.00  in INmune Bio on November 4, 2024 and sell it today you would earn a total of  392.00  from holding INmune Bio or generate 73.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

INmune Bio  vs.  Anixa Biosciences

 Performance 
       Timeline  
INmune Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in INmune Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, INmune Bio sustained solid returns over the last few months and may actually be approaching a breakup point.
Anixa Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

INmune Bio and Anixa Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INmune Bio and Anixa Biosciences

The main advantage of trading using opposite INmune Bio and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.
The idea behind INmune Bio and Anixa Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope